Houston, TX (PRWEB) April 6, 2011
firm mattress, a leading national retailer of bedding, has appointed the Translational Genomics Research Institute (TGen) as his? Charity partner of choice.? Specifically, firm mattress support globalCure, an alliance led by TGen scientists before anyone else, doctors, and advocates of pancreatic cancer in the fight against pancreatic cancer.
Steve Stagner, firm mattress? s CEO, believes the company? s support of research at the Phoenix-based TGen will offer employees the opportunity to change lives and awareness of pancreatic cancer with every customer interaction.
To launch his
Alignment globalCure TGen s?, firm mattress, in partnership with Simmons Bedding Co., makers of Beautyrest mattress, in a promotion that will donate $ 50 to globalCure for each soil sample dual Simmons Beautyrest sold nationally at nearly 700 stores firm mattress on April 6 by April 17. The goal is to raise over $ 100,000 for globalCure.
? Not only will we participate in local and national events to raise funds to support research at TGen, but we will also use opportunities to educate our customers and communities about pancreatic cancer and effort globalCure. Awareness is the key to progress, and we can make a significant impact in our lives? Stagner said.
Jai Pausch, a member of the National Consultative globalCure, praised Stagner and retailer based in Houston mattress. Pausch became a national spokesman for pancreatic cancer after the death of her husband, Randy, a professor at Carnegie Mellon and author of the bestseller, The Last Lecture.
? As an advocate who understands the devastating effects of pancreatic cancer can be for patients and their families, I commend firm mattress? s commitment to globalCure, and their efforts to provide needed resources and attention to our struggle? Pausch said.
Stagner said he hoped that firm mattress? s support will multiply through globalCure and are looking for pancreatic cancer and the discovery that the foundation Susan G. Komen has done for the fight against breast cancer.
? We have an opportunity to educate our customers about our efforts beyond the sales floor. We have an opportunity to get involved and engaged with the community and the impact on the lives of more than 43,000 Americans are diagnosed with pancreatic cancer each year? Stagner said.
Pancreatic cancer is the nation? the fourth leading cause of cancer deaths and is the only one of the 10 most deadly cancers with a survival rate to single digits. Nearly 75 percent of the 43,000 Americans diagnosed each year die in the first year. Only 6 percent survive more than five years. In addition, less than 2 percent of the National Cancer Institute? S federal research funding dedicated to research of pancreatic cancer.
According to Dr. Daniel D. Von Hoff, TGen? s chief medical officer and one of the world? s leaders on pancreatic cancer, early detection of pancreatic cancer is lacking, the survival rate remains low, and federal funding is a net to a river of need.
Discoveries follow directly funding and pancreatic cancer receives little in comparison with the percentage of living thing, “said Dr. Von Hoff, who heads the team of 46 doctors from around the world that form the backbone of globalCure.? Given the commitment of firm mattress will raise globalCure? s efforts, and money raised will enable us to aggressively pursue the underlying genetic causes of disease and lead an unprecedented number of new therapeutic approaches for patient care.
globalCure allow the international team of doctors to move quickly on promising new therapies clinics. Specifically, the funds allow scientists and clinicians to globalCure: identify diagnostic biomarkers as drug targets, identify and improve new agents that affect the activity of these objectives and evaluate new agents and take The most promising clinical trials for patients with advanced pancreatic cancer.
Houston-based firm mattress (http://www.mattressfirm.com) is one of the nation? s premier specialty bedding retailers, offering a wide selection of two conventional and specialty mattresses from leading manufacturers, including Tempur-Pedic, Sealy, Simmons and Stearns & Foster. Founded in 1986, firm mattress? S goal is to improve the life of a night at a time. With over 600 stores in 23 states, firm mattress offers consumers the benefit of a solid, competent sales professionals, a wide range of products and competitive prices in an attractive and comfortable store. Mattress firm is majority owned by JW Childs Associates, LP (? JWC?) A private equity firm based in Boston, MA invest in consumer products and middle market companies specializing in retail growth. Since 1995, JWC has invested in over 40 companies with a total value of over $ 12 billion. http://www.mattressfirm.com.
The Translational Genomics Research Institute (TGen) is a Phoenix, Arizona non-profit organization dedicated to conducting research with life changing results. Research at TGen is designed to help patients with diseases such as cancer, neurological disorders and diabetes. TGen is on the cutting edge of translational research where investigators are able to unravel the genetic components of common and complex diseases. Working with collaborators in the scientific and medical communities, TGen believes it can make a substantial contribution to the efficiency and effectiveness of the translation process. TGen is affiliated with the Van Andel Research Institute in Grand Rapids, Michigan. For more information, visit: http://www.tgen.org
is an exciting new initiative that encompasses a full range of cross-disciplinary groups in a coordinated effort to help patients with pancreatic cancer in the short term and ultimately put an end to this devastating disease. For more information, visit http://www.gcure.org.
TGen Science Senior Editor
syozwiak (at) Tgen (dot) org
firm mattress Communications Specialist
Cole (dot) mark (at) mattressfirm (dot) com
# # #